Cover image
MCHP (©StockStory)

1 Volatile Stock with Promising Prospects and 2 We Ignore


Jabin Bastian /
2026/02/16 11:34 pm EST

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

At StockStory, our job is to help you avoid costly mistakes and stay on the right side of the trade. Keeping that in mind, here is one volatile stock with massive upside potential and two that might not be worth the risk.

Two Stocks to Sell:

Microchip Technology (MCHP)

Rolling One-Year Beta: 2.10

Spun out from General Instrument in 1987, Microchip Technology (NASDAQ: MCHP) is a leading provider of microcontrollers and integrated circuits used mainly in the automotive world, especially in electric vehicles and their charging devices.

Why Do We Pass on MCHP?

  1. Sales tumbled by 3.8% annually over the last five years, showing market trends are working against its favor during this cycle
  2. Earnings per share decreased by more than its revenue over the last five years, showing each sale was less profitable
  3. Free cash flow margin dropped by 15.9 percentage points over the last five years, implying the company became more capital intensive as competition picked up

Microchip Technology is trading at $77.91 per share, or 32.3x forward P/E. Check out our free in-depth research report to learn more about why MCHP doesn’t pass our bar.

Enovis (ENOV)

Rolling One-Year Beta: 1.58

With a focus on helping patients regain or maintain their natural motion, Enovis (NYSE:ENOV) develops and manufactures medical devices for orthopedic care, from injury prevention and pain management to joint replacement and rehabilitation.

Why Should You Dump ENOV?

  1. Sales tumbled by 6.5% annually over the last five years, showing market trends are working against its favor during this cycle
  2. Earnings per share have dipped by 5.7% annually over the past five years, which is concerning because stock prices follow EPS over the long term
  3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

At $21.77 per share, Enovis trades at 6.7x forward P/E. Read our free research report to see why you should think twice about including ENOV in your portfolio.

One Stock to Watch:

Coherent (COHR)

Rolling One-Year Beta: 2.10

Created through the 2022 rebranding of II-VI Incorporated, a company with roots dating back to 1971, Coherent (NYSE:COHR) develops and manufactures advanced materials, lasers, and optical components for applications ranging from telecommunications to industrial manufacturing.

Why Is COHR on Our Radar?

  1. Impressive 16.6% annual revenue growth over the last two years indicates it’s winning market share this cycle
  2. Market share is on track to rise over the next 12 months as its 24.1% projected revenue growth implies demand will accelerate from its two-year trend
  3. Earnings per share have massively outperformed its peers over the last two years, increasing by 69.9% annually

Coherent’s stock price of $216.49 implies a valuation ratio of 34.4x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.